Liu FH

No ORCID on file · 6 papers in corpus · active 2021-2025
2025
Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017.
EClinicalMedicine ·doi:10.1016/j.eclinm.2024.102983

BackgroundOvarian cancer (OC) is a heterogeneous malignancy with multiple histological subtypes, showing global variability in incidence. Temporal changes in diagnostic criteria and risk factors might influence the incidence and distributio…

2023
Non-Genetic Factors and Risk of Cervical Cancer: An Umbrella Review of Systematic Reviews and Meta-Analyses of Observational Studies.
International journal of public health ·doi:10.3389/ijph.2023.1605198

Objectives: The association between non-genetic risk factors and cervical cancer (CC) remains controversial and unclear. This umbrella review was conducted to evaluate and synthesize previously published systematic reviews and meta-analyses…

2022
Review of Mendelian Randomization Studies on Endometrial Cancer.
Frontiers in endocrinology ·doi:10.3389/fendo.2022.783150

Endometrial cancer (EC) is a common gynecological cancer. In some parts of the world, the incidence and mortality of EC are on the rise. Understanding the risk factors of EC is necessary to prevent the occurrence of this disease. Observatio…

2022
The sirtuin family in health and disease.
Signal transduction and targeted therapy ·doi:10.1038/s41392-022-01257-8

Sirtuins (SIRTs) are nicotine adenine dinucleotide(+)-dependent histone deacetylases regulating critical signaling pathways in prokaryotes and eukaryotes, and are involved in numerous biological processes. Currently, seven mammalian homolog…

2021
Association between baseline LH/FSH and live-birth rate after fresh-embryo transfer in polycystic ovary syndrome women.
Scientific reports ·doi:10.1038/s41598-021-99850-4

This study aimed to retrospectively analyse the effect of the baseline luteinising hormone/follicle-stimulating hormone ratio (bLH/FSH) on the live-birth rate per fresh-embryo transfer cycle (LBR/ET) in infertile women with polycystic ovary…

2021
The Clinical Efficacy of Three Different Follicle-Stimulating Hormones for Follicle Growth and Development in Long-Protocol Controlled Ovarian Hyperstimulation Treatment.
Drug design, development and therapy ·doi:10.2147/dddt.s316189

ObjectiveTo compare the use and clinical efficacy of three different follicle-stimulating hormones (FSHs) for follicle growth and development in long-protocol controlled ovarian hyperstimulation (COH).MethodsA total of 540 gonadotropin-rele…